Exact Mass: 487.0426572

Exact Mass Matches: 487.0426572

Found 32 metabolites which its exact mass value is equals to given mass value 487.0426572, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Carbovir Triphosphate

({[({[(1S,4R)-4-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)cyclopent-2-en-1-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid

C11H16N5O11P3 (487.0059176)


Carbovir Triphosphate belongs to the class of organic compounds known as nucleoside and nucleotide analogues. These are analogues of nucleosides and nucleotides. These include phosphonated nucleosides, C-glycosylated nucleoside bases, analogues where the sugar unit is a pyranose, and carbocyclic nucleosides, among others.

   

8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP

2-amino-8-[(4-chlorophenyl)sulfanyl]-9-{2,7-dihydroxy-2-oxo-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl}-6,9-dihydro-1H-purin-6-one

C16H15ClN5O7PS (487.011832)


   

CAY10575

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H21N3O6S2 (487.08717260000003)


   
   
   
   

L-Histidine,N,1-bis(2,4-dinitrophenyl)-

L-Histidine,N,1-bis(2,4-dinitrophenyl)-

C18H13N7O10 (487.0723878)


   

2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine

2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine

C29H18BrN3 (487.0684008)


   
   

3-(2-naphthyloxy)-4-oxo-4H-chromen-7-yl 5-bromonicotinate

3-(2-naphthyloxy)-4-oxo-4H-chromen-7-yl 5-bromonicotinate

C25H14BrNO5 (487.00552940000006)


   

6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one

6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one

C21H22BrN5O2S (487.06774920000004)


   
   

4:2 Fluorotelomer thioether amido sulfonic acid

4:2 Fluorotelomer thioether amido sulfonic acid

C13H18F9NO4S2 (487.0533496)


   

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H21N3O6S2 (487.08717260000003)


   

2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid

2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid

C16H18N5O11P (487.0740408)


   

8-((4-Chlorophenyl)thio)cyclic-3,5-GMP

8-((4-Chlorophenyl)thio)cyclic-3,5-GMP

C16H15ClN5O7PS (487.011832)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

8-Pcpt-cgmp

8-Pcpt-cgmp

C16H15ClN5O7PS (487.011832)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-

Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-

C18H22IN3O3S (487.0426572)


   

2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide

2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide

C24H17N5O3S2 (487.07727719999997)


   

2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide

2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide

C21H18BrN3O4S (487.02013280000006)


   

N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide

N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide

C22H18ClN3O6S (487.06047980000005)


   

(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide

(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide

C21H18FN5O4S2 (487.07842)


   

5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester

5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester

C21H18FN5O4S2 (487.07842)


   

SB 271046 (Hydrochloride)

SB 271046 (Hydrochloride)

C20H23Cl2N3O3S2 (487.05578280000003)


SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively. SB 271046 Hydrochloride is over 200 fold selective for the 5-HT6 receptor vs 55 other receptors, binding sites and ion channels. Anticonvulsant activity (EC50=0.16 μM)[1].

   

4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid

4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid

C18H25Cl4N3O2S (487.04215100000005)


   

(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

C23H22BrNO6 (487.06304120000004)


   

8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

C23H22BrNO6 (487.06304120000004)


   

(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol

C23H22BrNO6 (487.06304120000004)